Evidence map›Paper›PMID 35222028›Full record

ArticleFrontiers in pharmacology2022

The Pore-Forming Subunit C2IIa of the Binary

Julia Eisele, Simone Schreiner, Joscha Borho, Stephan Fischer, Sebastian Heber, Sascha Endres, Maximilian Fellermann, Lisa Wohlgemuth, Markus Huber-Lang, Giorgio Fois and 3 more

Abstract read
In one paragraph

Article in Frontiers in pharmacology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. TheToxins · 2023
    Article
  8. Review
  9. Toxins · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Julia EiseleInstitute of Pharmacology and Toxicology, Ulm University Medical Center, Ulm, Germany.
Simone SchreinerInstitute of Pharmacology and Toxicology, Ulm University Medical Center, Ulm, Germany.
Joscha BorhoInstitute of Pharmacology and Toxicology, Ulm University Medical Center, Ulm, Germany.
Stephan FischerInstitute of Pharmacology and Toxicology, Ulm University Medical Center, Ulm, Germany.
Sebastian HeberInstitute of Pharmacology and Toxicology, Ulm University Medical Center, Ulm, Germany.
Sascha EndresInstitute of Pharmacology and Toxicology, Ulm University Medical Center, Ulm, Germany.
Maximilian FellermannInstitute of Pharmacology and Toxicology, Ulm University Medical Center, Ulm, Germany.
Lisa WohlgemuthInstitute of Clinical and Experimental Trauma Immunology, Ulm University Medical Center, Ulm, Germany.
Markus Huber-LangInstitute of Clinical and Experimental Trauma Immunology, Ulm University Medical Center, Ulm, Germany.
Giorgio FoisInstitute of General Physiology, Ulm University, Ulm, Germany.
Michael FaulerInstitute of General Physiology, Ulm University, Ulm, Germany.
Manfred FrickInstitute of General Physiology, Ulm University, Ulm, Germany.
Holger BarthInstitute of Pharmacology and Toxicology, Ulm University Medical Center, Ulm, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The binary C2 toxin of

Indexed as

binary C2 toxinchemotaxisClostridium botulinummigrationpolymorphonuclear leukocytestrans-membrane channeltransport subunit C2IIa

Identifiers

PMID35222028
PMCPMC8881014

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.